Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: combination therapy to prevent ibrutinib flare
Hampel, Paul J., Call, Timothy G., Ding, Wei, Muchtar, Eli, Kenderian, Saad S., Wang, Yucai, Leis, Jose F., Witzig, Thomas E., Koehler, Amber B., Fonder, Amie L., Schwager, Susan M., Rabe, Kari G., VaJournal:
American Journal of Hematology
DOI:
10.1002/ajh.25690
Date:
December, 2019
File:
PDF, 1017 KB
2019